Clinical Trial Update: Efficacy and Safety of Aliskiren and Atenolol in Adults (>18) With Mild to Moderate Hypertension [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy and safety of aliskiren and atenolol in adults with mild to moderate hypertension has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Aliskiren (Aliskiren)
• Atenolol (Atenolol)

Snippet

Sponsor: Novartis | Conditions: Hypertension | Phase 3 | Status: COMPLETED